fl-Amyloido 42) peptide ( flAP 0 _42)) was injected into the medial septum of rats. After a 14-day survival time, neuronal alterations in the septal cholinergic and GABAergic systems were visualized by means of histo-and immunocytochemical methods. Neurons insulted by the peptide were primarily choline acetyltransferase-immunoreactive (ir), while only minor effects of flAP~v4: ) were observed on parvalbumin-ir interneurons. These results indicate that the changes in intracellular Ca 2+ level elicited by flAP(l_42 ) may contribute to /3-amyloid neurotoxicity, and Ca2+-binding proteins may play an important role in the protection against the neurotoxic effects of ~AP, 421. The sole invariant hallmark of Alzheimer's disease (AD) is the presence and excessive accumulation of /3-amyloid peptides (/3AP) forming neuritic plaques [21] . Alternative processing of the amyloid precursor protein liberates potentially amyloidogenic /3AP [22] that consist of 39-42 amino acid residues [12] . Small amounts of /3AP exert trophic properties on neurons in culture [25] , while treatment of neurons with high concentrations of these proteins causes neurodegeneration and cell death in vitro [16, 25] . Recent studies have shown that in vivo administration of /3AP elicits the malfunction of neurons, leading, for instance, to a reduced acetylcholine release of neurons from the medial septum (MS) of rats [1] . The precise mechanism of how /3AP accumulation and deposition induce neuronal changes in the early stages of AD is still sketchy [17, 21] , but it has recently emerged that these peptides exhibit cholinotoxicity [1, 13] , contributing directly to the impairment of cognitive, learning and memory functions in AD. Contemporary results, however, support the hypothesis that /3AP act by altering intracellular Ca 2+ concentrations ([Ca 2+ ]i) [17, 18] , while a Ca 2+ overload is
The sole invariant hallmark of Alzheimer's disease (AD) is the presence and excessive accumulation of /3-amyloid peptides (/3AP) forming neuritic plaques [21] . Alternative processing of the amyloid precursor protein liberates potentially amyloidogenic /3AP [22] that consist of 39-42 amino acid residues [12] . Small amounts of /3AP exert trophic properties on neurons in culture [25] , while treatment of neurons with high concentrations of these proteins causes neurodegeneration and cell death in vitro [16, 25] . Recent studies have shown that in vivo administration of /3AP elicits the malfunction of neurons, leading, for instance, to a reduced acetylcholine release of neurons from the medial septum (MS) of rats [1] . The precise mechanism of how /3AP accumulation and deposition induce neuronal changes in the early stages of AD is still sketchy [17, 21] , but it has recently emerged that these peptides exhibit cholinotoxicity [1, 13] , contributing directly to the impairment of cognitive, learning and memory functions in AD. Contemporary results, however, support the hypothesis that /3AP act by altering intracellular Ca 2+ concentrations ([Ca 2+ ]i) [17, 18] , while a Ca 2+ overload is known to be toxic to neurons [6] . Thus, /3AP may also render neurons vulnerable (directly or indirectly) to different kinds of intracellular insults by disrupting normal intracellular Ca 2 + homeostasis.
The MS plays an important role in learning and memory processes via the septo-hippocampal pathway [11] . Primarily cholinergic and y-aminobutyric acid (GABA)ergic neurons, in approximately equal quantities, are situated in the MS of rats [23] . GABAergic neurons in the MS contain the Ca2+-binding protein parvalbumin (PV) [9] , which plays a principal role in buffering the cytosolic free Ca 2+ levels [2, 5] . While pathogenic changes in the cholinergic system can readily be demonstrated in the early stages of AD [3, 21] , PV-immunoreactive (ir) neurons represent a neuronal subset more resistant to degeneration in AD [14] .
Since controversial results have recently been published as to whether flAP may have specific effects on different populations of neurons in vitro [15, 20] , we have determined the effects of one such peptide on septal cholinergic and GABAergic, PV-containing neurons in vivo.
The synthesis of human fl-amyloido_42 ~ peptide (/3AP¢1-42)) has been previously described in detail [13] . In brief, /3AP(l_42 ) was synthesized with amide at the C-.terminal by a solid-phase technique involving Boc chem-istry. Peptide chains were elongated on MBHA resin (0.6-0.8 mmol/g) and the syntheses were carried out manually. Couplings were performed with dicyclohexylcarbodiimide, with the exception of Asn, which was incorporated in HOBt-ester form. The Boc group was removed by treatment with 50% trifluoroacetic acid (TFA) in CHzCi 2. After completion of the synthesis, the peptide was cleaved from the resin with liquid HF. Free peptides were solubilized in 95% TFA, filtered and lyophilized. The crude peptides were purified by reverse-phase high pressure liquid chromatography (RP-HPLC) on an Astec-300-5 C 4 column. The purity was checked by RP-HPLC on a WPorex-5 C 4 column. Amino acid analysis demonstrated the expected amino acid composition, and electrospray mass spectrometry gave the expected molecular ion. lAP(l_42 ) was dissolved in 30% acetonitrile containing 0.1% TFA when used in the experiments. Ten male Wistar rats (320-370 g), divided into two groups (5 control and 5 treated animals), were used in these experiments. The animals were injected with 1 /xl of 0.35 nmol/1 /xl fAP(l_42 ) into the MS (~ 0.1 /zl/min; AP = 0.2 mm, L = 0.3 mm, H = 6.0 mm from the bregma at an angle of 5 °, [19] ), under 0.12 ml 6% sodium pentobarbital (i.p.)/0.12 ml Hypnorm (i.m., Janssen, The Netherlands)/0.1 ml methyl atropine sulfate (i.p.) anaesthesia. Control animals received the same volume of the organic solvent only. After a 14-day survival time, all rats were deeply anaesthetized with 6% sodium pentobarbital and transcardially perfused with a 50 ml prerinse of heparinized saline. This was followed by 300 ml fixative containing 3% paraformaldehyde (PFA) and 0.2% picric acid solution. Brains were cryoprotected overnight at 4°C in 30% phosphate-buffered sucrose. Coronal cryostat sections (20/.Lm) were cut and collected in phosphate-buffered saline (PBS; 0.01 M, pH 7.4). Silver staining was performed according to the method of Gallyas et al. [10] . Briefly, the cortical sections were postfixed overnight in 4% PFA, then pretreated in a solution of 2% NaOH and 2.5% NHaOH, followed by impregnation in a mixture containing 0.5% AgNO 3, 0.8% NaOH and 2.5% NHaOH. After the sections had been rinsed several times in a solution of 0.01% NH4NO 3 and 0.5% NazCO 3 in 30% ethanol, staining was developed in a solution containing 0.01% citric acid, 0.5% formaldehyde and 10% ethanol. After washing of the sections several times in 0.5% acetic acid, the reaction was stopped with Na2S20 3.
Tissue sections processed for choline acetyltransferase (CHAT; EC 3.2.1.6) immunocytochemistry were rinsed several times in 0.01 M PBS, immersed in 0.3% H20 2 in PBS, rinsed again and incubated for 1 h at room temperature (RT) in 5% normal rabbit serum (NRS; Zymed, San Francisco, CA, USA) diluted in 0.2% Triton X-100 and azide-containing PBS under gentle movement of the incubation medium. Free-floating sections were incubated with goat anti-ChAT IgG, as primary antibody (kindly donated by Dr. L.B. Hersh [4] ) diluted 1:2000 in 1% NRS and 0.2% Triton X-100 at 37°C for two days. After incubation, sections were thoroughly rinsed in PBS, preincubated for 1 h with NRS, followed by the second antibody incubation for 1.5 h at 37°C. The second antibody was rabbit anti-goat IgG (1:80; Sigma, St. Louis, MO, USA). Sections were rinsed overnight in PBS before the third incubation step (2 h at RT) in goat peroxidase-anti-peroxidase (PAP; 1:300; Dakopatts, Glosstrup, Denmark), diluted in Triton X-100-PBS. Finally, the peroxidase was visualized with 3,3'-diaminobenzidine (DAB) as chromogen (30 mg/100 ml) and 0.01% H202. Between incubation steps, brain samples immunostained for PV were always rinsed at least four times with PBS to which 0.5% Triton X-100 had been added. Prior to the first antibody incubation, sections were exposed to 0.1% H202 for 15 min and 5% normal sheep serum (NSS; Jackson, West Grove, PA, USA) for 30 min at RT. Sections were then incubated overnight at 4°C with the primary monoclonal antibody, mouse anti-PV IgG (1:2000; Sigma), which recognizes the Ca2+-bound conformation of PV. After rinsing, sections were again incubated for 30 min in 5% NSS and exposed to biotinylated sheep anti-mouse IgG (1:200 in PBS, 2 h at RT; Amersham, Bucks, UK) and streptavidin-HRP (1:200 in PBS, 1 h at RT; Zymed, USA). Tissue-bound peroxidase was visualized by means of the same DAB-H202 reaction as described above. Standard control experiments were performed by omission of the primary antibodies, which did not yield any detectable immunoprecipitate (data not shown).
After a 14-day survival time silver staining of MS sections revealed extensive degenerating processes in fAP(l_42)-treated animals as compared with the controls (Fig. 1A,B) . Degenerating fibers were scattered throughout the MS (Fig. 1A) and they also appeared in efferent pathways (e.g. in the medial forebrain bundle; data not shown). In the control animals, only the needle-track was densely stained (Fig. 1B) , revealing the effects of the operation trauma. The loss of the ChAT-it neurons and a marked decrease in ChAT-immunoreactivity were observed after fAP(l 42) treatment, as compared with the control animals (Fig. 1C,D,E) . As a result of neurodegenerative processes, the ChAT-ir neurons exhibited perikaryal shrinkage, while the degenerating and ChAT-ir processes had a beaded appearance, which is a characteristic feature of degenerating fibers (Fig. ID) . While the ChAT-ir neurons were clustered in the lateral zone and in the midline area of the MS, the PV-containing GABAergic interneurons were situated in its central portion. In spite of the fact that the central area of the MS was primarily damaged during the injection procedure, the PV-positive neurons displayed only a limited change after injection of lAP(l_42), relative to the controls (Fig. 1F,G) . Alteration of the PV-ir neurites rarely occurred, and only a slight decrease in PV-immunoreactivity was observed after /3AP(~_42 ) treatment. These changes were inconspicuous when compared to the characteristic degenerative changes in the ChAT-it neurons.
Quantitative analysis of septal sections revealed a significant loss of ChAT-ir neurons after/3AP o_42) injections, as compared with the controls (46.71 + 9.1 vs. 62_ 6.4 neuron/MS, P < 0.01; Fig. 2 ). Analysis of our data revealed a slight decrease in the number of PV-ir septal neurons, albeit not significant in comparison with the controls (54.25 + 2.9 vs. 56.63 + 4.4 neuron/MS; Fig. 2 ).
The observations yielded by silver-and ChAT-immunolabelling in the present study are consistent with previous in vivo data of ourselves [13] and others [1] , suggesting that flAP exert toxic effects on cholinergic neurons when injected into the rat brain. Analogous with the present results, Dong et al. [7] reported that intracere- however, that PV-ir neurons may also be affected by 13AP~1_42 ~ but changes of PV gene expression may mask this neuronal damage by upregulation of the synthesis of the peptide. In summary, the present report provides histochemical evidence that /3APCj 42), the major amyloid component of neuritic plaques, induces a specific cellular injury of septal cholinergic neurons, whereas the GABAergic, PV-positive neurons were relatively spared. As PV has been shown to be present within most of the GABAergic interneurons of the ms [9] , our in vivo results support the observations thal GABAergic neurons are resistant to /3AP neurotoxicity [20] . Since the GABAergic neurons are so richly provided with the Ca2+-binding protein, this characteristic supports the hypothesis of deranged [Ca2+]i homeostasis in /3AP induced cell damage. For that reason the cholinergic neurons in the MS are more sensitive to /3AP induced damage. broventricular infusion of AF64A reduced the number of ChAT-ir neurons in the MS, while PV-ir interneurons remained unaffected. Moreover, it has recently been reported that GABAergic neurons are resistant to /3AP neurotoxicity in vitro [20] . Histochemical analysis of AD brains corroborates these results, as PV-containing populations of neurons seemed to be preserved in AD [14] . For example, Ferret et al. [8] reported that PV-ir dystrophic neurites and aberrant terminal sprouts had been found associated with senile plaques, while the density of the PV-ir neurons in the cerebral cortex remained unaffected in AD. These data support our present observations in rats, as the PV-ir neurons of the MS seemed to be less affected after/3AP{~_ 42) treatment, although some changes occurred in the PV-ir neurites. It is interesting to speculate as to the role of the Ca 2 +-binding protein PV in the prevention of /3AP neurotoxicity. We have therefore focused our attention on the role of PV in the protection of neurons against /3AP neurotoxicity, via buffering of the [Ca 2+]i. As outlined earlier [17] , /3AP toxicity is mediated by alterations in the Ca 2~ homeostasis of the neurons. In addition, the Ca 2+ channel blocker nimodipine was able to attenuate the effects of /3AP [24] , suggesting the principal role of the Ca 2+ overload in /3AP-induced neurotoxicity. PV is known to regulate [Ca 2~ ]~ through the active binding of free, cytosolic Ca -'~ . This regulatory role of the Ca2+-binding
